Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer /

Saved in:

Bibliographic Details
Imprint:	Rockville, Md. : The Agency, [1999]
Description:	1 volume (various pagings) : illustrations.
Language:	English
Series:	Evidence report/technology assessment ; no. 4 AHCPR publication ; no. 99-E0012 AHCPR pub. ; no. 99-E 0012. Evidence report/technology assessment ; no. 4.
Subject:	Antiandrogens -- Therapeutic use. Prostate -- Cancer -- Hormone therapy. Prostatic Neoplasms -- drug therapy. Antineoplastic Agents, Hormonal -- therapeutic use. Cost-Benefit Analysis. Gonadotropin-Releasing Hormone -- agonists. Treatment Outcome. Meta-Analysis.
Format:	E-Resource U.S. Federal Government Document Book
URL for this record:	http://pi.lib.uchicago.edu/1001/cat/bib/6516526

Hidden Bibliographic Details
Varying Form of Title:	Relative effectiveness and cost effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer
Other authors / contributors:	Aronson, Naomi. United States. Agency for Health Care Policy and Research. Blue Cross and Blue Shield Association.
Notes:	"Contract no. 290-97-0015." "May 1999." Not distributed to depository libraries in a physical form. Includes bibliographical references. Available via Internet from the National Library of Medicine web site. Address as of 10/2/01: http://hstat.nlm.nih.gov/ftrs/pick?collect=epc&dbName=prost&cd=1&t=1002035486; current access is available via PURL.
GPO item no.:	0491-B-31 (online)
Govt.docs classification:	HE 20.6524:4

Similar Items